跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ONE-001
首页
药物
ONE-001
ONE-001
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
NON-VIABLE BIFIDOBACTERIUM BIFIDUM BACTERIA AND USES THEREOF
EP 3810161 A1
申请人: SYNFORMULAS GMBH
优先权: 2018
CN
EP
US
WO
4 件公开
ACTIVATORS OF CLASS 1 HISTONE DEACETYLASES (HDACS) AND USES THEREOF
EP 3483150 A1
申请人: MASSACHUSETTS INST TECHNOLOGY
优先权: 2011
EP
US
4 件公开
ORAL PCLX-001 IN THE TREATMENT OF HUMAN CANCER
EP 4486344 A4
申请人: PACYLEX PHARMACEUTICALS INC
优先权: 2022
CN
EP
US
3 件公开
METHODS FOR TREATING EYE DISEASES USING LIPID BINDING PROTEIN-BASED COMPLEXES
US 20250230208 A1
申请人: ABIONYX PHARMA SA
优先权: 2022
CN
US
2 件公开
NOVEL LACTIC ACID LACTIPLANTIBACILLUS PLANTARUM SKO-001 BACTERIUM FOR REDUCING BODY FAT, AND USES THEREOFHH
EP 4581940 A1
申请人: KOLMAR BNH CO LTD
优先权: 2022
CN
EP
2 件公开
Proteins that bind PI16 and uses thereof
US 9605079 B2
申请人: BARRY SIMON
优先权: 2011
US
2 件公开
Reliable stabilization of N-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns
US 8906681 B2
申请人: KELLY JEFFERY W
优先权: 2012
US
2 件公开
Novel pharmaceutical compositions and methods for treating tumors, including drug-resistant tumors
US 2007054908 A1
申请人: DONG ZHONGYUN
优先权: 2006
US
Combination therapies
CN 107106687 A
申请人: NOVARTIS AG
优先权: 2014
CN
Beverage with collagen and additional additives
CN 107205448 A
申请人: WELLDRINKS LTD
优先权: 2015
CN
第 1 / 3 页
上一页
下一页
药物
反馈